Expert reveals how Queen could play key role if coronavirus vaccine becomes available  ExpressView Full coverage on Google News
THE QUEEN could play a key role if a coronavirus vaccine becomes available, according to an expert.THE QUEEN could play a key role if a coronavirus vaccine becomes available, according to an expert.

Queen news: Queen could play key role if coronavirus vaccine becomes available - expert | Royal | News | Express.co.uk

Inspections will be carried out at 3 companies that have agreed to supply COVID-19 vaccines to Indonesia - Anadolu AgencyInspections will be carried out at 3 companies that have agreed to supply COVID-19 vaccines to Indonesia - Anadolu Agency

Indonesian team in China to check COVID-19 vaccines

A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus is safe and eli

Preliminary results show Chinese COVID-19 vaccine candidate safe: The Lancet - SHINE News

50 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-1950 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-19

50 African Diplomats on Anti-Covid-19 Visit to China’s Sinopharm | Africanews

Vaccine misinformation expert Professor Heidi Larson said the Queen, 94, should get the anti-Covid vaccine to boost the public's trust and help dispel fears about the vaccination.Vaccine misinformation expert Professor Heidi Larson said the Queen, 94, should get the anti-Covid vaccine to boost the public's trust and help dispel fears about the vaccination.

Queen should get anti-Covid jab to persuade public to trust vaccination when it becomes available | Daily Mail Online

Treatment is safe and elicits an antibody response, preliminary results have shownTreatment is safe and elicits an antibody response, preliminary results have shown

'Enouraging' Chinese Covid vaccine shows early promise - Wales Online

403 Missing Auth Token

Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.

China's Covid-19 vax is safe, prompts antibody response: Lancet | greatandhra.com

COVID-19 vaccine, and China-Africa health cooperation, are their focus.

50 African diplomats visit Chinese coronavirus vaccine maker - CGTN

But, er, Professor Heidi Larson also admits palace may not wish to ‘risk’ giving 94-year-old new jabBut, er, Professor Heidi Larson also admits palace may not wish to ‘risk’ giving 94-year-old new jab

Coronavirus: Queen could be used to dispel vaccine fears, government expert suggests | The Independent

Welcome to The Star’s live news blog on Saturday, October 17.Welcome to The Star’s live news blog on Saturday, October 17.

Coronavirus in Sheffield LIVE, October 17: National circuit-breaker 'may be necessary' as talks continue on city's alert level | The Star

Government adviser Professor Heidi Larson has told ministers it would be "really really smart" to use her majesty to fight against dangerous anti-vaccine conspiracy theories Government adviser Professor Heidi Larson has told ministers it would be "really really smart" to use her majesty to fight against dangerous anti-vaccine conspiracy theories

The Queen may be used by government to boost public trust in new coronavirus vaccines - Daily Star

A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.

Chinese COVID-19 vaccine candidate shows promise in human trial: Study | Health

(This October 16 story was refiled to correct spelling of city Jiaxing in 4th paragraph)(This October 16 story was refiled to correct spelling of city Jiaxing in 4th paragraph)

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60 | Reuters

Health authorities in Jiaxing, East China’s Zhejiang Province, announced on Thursday that the city has been administering China’s homegrown inactivated COVID-19 vaccines among high-risk groups and would gradually offer it to ordinary citizens for urgent use.

Eastern Chinese cities to offer ordinary citizens COVID-19 vaccines - Global Times

NewZimbabwe.com – The Zimbabwe News You Trust is Zimbabwe’s leading online newspaper and published by New Zimbabwe Media Ltd. The platform brings you the latest breaking News, Business, Showbiz, Sports, Diaspora and gives you everything you’ve come to expect and love.Spread This NewsMailOnLine Hopes of getting a Covid-19 vaccine were boosted again today after an experimental Chinese jab was found to be safe and produce an immune response. Every volunteer given a double-dose of state-owned firm Sinopharm’s vaccine made antibodies against SARS-CoV-2, the coronavirus that causes Covid-19. In theory, this would protect them from catching

More Covid-19 vaccine hopes as scientists say experimental Chinese jab is safe - NewZimbabwe.com

A $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said Thursday residents aged between 18 and 59 with "urgent needs" can seek consultations at clinics for a Sinovac Biotech vaccine thatA $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet

$60 experimental coronavirus vaccine rolled out in eastern Chinese city | Deccan Herald

Scientists have warned that governments and tech firms need to tackle coronavirus misinformation.Scientists have warned that governments and tech firms need to tackle coronavirus misinformation.

Queen could help boost public’s trust in coronavirus vaccine, expert says | ITV News

Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59

Preliminary results show Chinese Covid-19 vaccine candidate safe | Dhaka Tribune

Results of BBIBP-CorV vaccine currently underway in UAE will provide information whether it is safe and efficacious.Results of BBIBP-CorV vaccine currently underway in UAE will provide information whether it is safe and efficacious.

Covid-19 vaccine on trial in UAE found safe in early stages: Study - News | Khaleej Times

The North Carolina Department of Health and Human Services released their interim COVID-19 vaccination plan Friday, once one is available.The North Carolina Department of Health and Human Services released their interim COVID-19 vaccination plan Friday, once one is available.

North Carolina unveils plan to deploy coronavirus vaccine

BEIJING • One of China's front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early-and mid-stage test in humans, researchers said.. Read more at straitstimes.com.East Asia News -BEIJING • One of China's front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early-and mid-stage test in humans, researchers

China vaccine candidate found safe in early tests, East Asia News & Top Stories - The Straits Times

Clinical trials of the coronavirus vaccine have involved 640 peopleClinical trials of the coronavirus vaccine have involved 640 people

Chinese Covid-19 vaccine candidate safe, early reports say | Metro News

China has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said theChina has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said the

The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.

Sinovac vaccine for Covid offered by Chinese city for emergency use costs $60 - world news - Hindustan Times

BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...

Study: Covid-19 vaccine candidate from China’s CNBG shows promise in human test | Life | Malay Mail

Hope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet Infectious Disease, is based on small early phase randomised clinical trials involving 640 participants. The vaccine candidate is based on inactivated coronavirus. Scientists said thoseHope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet

Hope for coronavirus vaccine boosted as scientists say Chinese jab safe and produces immune response | London Evening Standard

Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.

Covid-19: China rapidly expands use of its experimental coronavirus vaccines - World News

China rapidly expands use of experimental COVID-19 vaccinesChina rapidly expands use of experimental COVID-19 vaccines

China rapidly expands use of experimental COVID-19 vaccines - CNA

The move is aimed at boosting public confidence in homegrown inoculations, the WSJ reported, citing a company website and some students who applied for it.

China's Sinopharm Offers Experimental COVID-19 Vaccines to Students - The Wire Science

The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.

Chinese Covid vaccine safe in phase 1 & 2 trials, generates antibodies, Lancet says

The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.

Chinese Covid vaccine safe in phase 1 & 2 trials, generates antibodies, Lancet says

A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...

€50 experimental COVID-19 vaccine rolled out in east Chinese city

The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of Biological Products, a subsidiary of China National Biotec GrThe potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of Biological Products, a subsidiary of China National Biotec Gr

Coronavirus vaccine candidate from China's CNBG shows promise in human test, study shows - Times of India

A Chinese drug developer is offering an experimental coronavirus vaccine to students going abroad in a strategy health experts say raises safety and ethical concerns. China National Biotech Group has two vaccine candidates out of five from Chinese developers that are in the final stages of clinicalA Chinese drug developer is offering an experimental coronavirus vaccine to students going abroad in a strategy health experts say raises safety and ethical concerns. China National Biotech Group has two vaccine candidates out of five from Chinese developers that are in the final stages of clinical

Chinese company offers coronavirus vaccine to students

China National Biotec Group is distributing its vaccine outside clinical trials, per The Wall Street Journal. Experts say this is incredibly risky.China National Biotec Group is distributing its vaccine outside clinical trials, per The Wall Street Journal. Experts say this is incredibly risky.

Chinese firm giving unproven COVID-19 vaccine to students going abroad - Business Insider

China is expanding distribution of coronavirus vaccines outside of clinical trials, with a state-owned company offering them to students going abroad amid a campaign by officials to boost public confidence in homegrown inoculations. China is expanding distribution of coronavirus vaccines outside of clinical trials, with a state-owned company offering them to students going abroad amid a campaign by officials to boost public confidence in homegrown inoculations.

China Drugmaker Gives Unproven Covid-19 Vaccine to Students Going Abroad - WSJ

State media reported the company was offering its vaccines to students in Beijing and Wuhan but that the trial had been suspendedState media reported the company was offering its vaccines to students in Beijing and Wuhan but that the trial had been suspended

China's Sinopharm offered experimental vaccine to students going abroad – reports | Coronavirus | The Guardian

This vaccine includes the killed virus mixed with aluminium hydroxide, which is known to boost immune responses.This vaccine includes the killed virus mixed with aluminium hydroxide, which is known to boost immune responses.

China's Covid-19 vaccine candidate is safe and prompts antibody response - early results from study

Data from a Phase 1/2 randomized controlled trial of vaccine candidate, BBIBP-CorV, is shown to be safe.Data from a Phase 1/2 randomized controlled trial of vaccine candidate, BBIBP-CorV, is shown to be safe.

COVID-19 Vaccine Induces Immune Response | Contagion Live

The Indonesian government has secured a supply of those vaccines, including 143 million doses of Sinovac vaccineThe Indonesian government has secured a supply of those vaccines, including 143 million doses of Sinovac vaccine

Indonesian Team in China for Covid-19 Vaccine Safety Audit

China's Covid-19 vaccine is safe, prompts antibody response: Lancet Greater Kashmir | Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibodyChina's Covid-19 vaccine is safe, prompts antibody response: Lancet Greater Kashmir | Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody

China's Covid-19 vaccine is safe, prompts antibody response: Lancet | Greater Kashmir

BEIJING: A Chinese city is offering Sinovac Biotech's experimental Covid-19 vaccine to essential workers and other high-risk groups as part of a natio...BEIJING: A Chinese city is offering Sinovac Biotech's experimental Covid-19 vaccine to essential workers and other high-risk groups as part of a natio...

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60 (RM 249)